What are the risk factors for endometrial cancer?
A risk factor is anything that changes your chance of getting a disease such as cancer. Different cancers have different risk factors. For example, unprotected exposure to strong sunlight is a risk factor for skin cancer. Smoking is a risk factor for many cancers.
There are different kinds of risk factors. Some, such as your age or race, can't be changed. Others are related to personal choices such as smoking, exercising, body weight, drinking, or diet. Some factors influence risk more than others. Although certain factors increase a woman's risk for developing endometrial cancer, they do not always cause the disease. Many women with one or more risk factors never develop endometrial cancer. Some women with endometrial cancer do not have any known risk factors. Even if a woman with endometrial cancer has one or more risk factors, there is no way to know which, if any, of these factors was responsible for her cancer.
A woman's hormone balance plays a part in the development of most endometrial cancers. Many of the risk factors for endometrial cancer affect estrogen levels. Before menopause, the ovaries are the main source of the 2 main types of female hormones -- estrogen and progesterone. The balance between these hormones changes during a woman's menstrual cycle each month. This produces a woman's monthly periods and keeps the endometrium healthy. A shift in the balance of these two hormones toward more estrogen increases a woman's risk for developing endometrial cancer. After menopause, the ovaries stop making these hormones, but a small amount of estrogen is still made naturally in fat tissue. This estrogen has a bigger impact after menopause than it does before menopause. Female hormones are also available to take (as a medicine) in birth control pills to prevent pregnancy and as hormone therapy to treat symptoms of menopause.
Treating the symptoms of menopause with estrogen is known as estrogen therapy or menopausal hormone therapy. Estrogen is available in many different forms such as pills, skin patches, creams, shots, and vaginal rings to treat the symptoms of menopause. Estrogen treatment can reduce hot flashes, improve vaginal dryness, and help prevent the weakening of the bones (osteoporosis) that can occur with menopause. Doctors have found, however, that using estrogen alone (without progesterone) can lead to endometrial cancer in women who still have a uterus. Progesterone-like drugs must be given along with estrogen to reduce the increased risk of endometrial cancer. This approach is called combination hormone therapy.
Giving progesterone along with estrogen does not cause endometrial cancer, but it does still have risks. Studies have shown that this combination increases a woman's chance of developing breast cancer and also increases the risk of serious blood clots.
Studies have shown that estrogen therapy increases a woman's chance of developing serious blood clots and heart disease. If you are taking (or plan to take) hormones after menopause, it is important for you to discuss the potential risks (including cancer, blood clots, heart attacks, and stroke) with your doctor. Like any other medicine, hormones should be used only at the lowest dose that is needed and for the shortest possible time to control symptoms. You should also have yearly follow-up pelvic exams. If you have any abnormal bleeding or discharge from the vagina you should see your doctor or other health care provider right away.
Birth control pills
Using birth control pills (oral contraceptives) lowers the risk of endometrial cancer. The risk is lowest in women who take the pill for a long time, and this protection continues for at least ten years after a woman stops taking this form of birth control. However, it is important to look at all of the risks and benefits when choosing a contraceptive method; endometrial cancer risk is only one factor to be considered. It's a good idea to discuss the pros and cons of different types of birth control with your doctor.
Total number of menstrual cycles
Having more menstrual cycles during a woman's lifetime raises her risk of endometrial cancer. Starting menstrual periods (menarche) before age 12 and/or going through menopause later in life raises the risk. Starting periods early is less a risk factor for women with early menopause. Likewise, late menopause may not lead to a higher risk in women whose periods began later in their teens.
The hormonal balance shifts toward more progesterone during pregnancy. So having many pregnancies protects against endometrial cancer. Women who have never been pregnant have a higher risk, especially if they were also infertile (unable to become pregnant).
Most of a woman's estrogen is produced by her ovaries, but fat tissue can change some other hormones into estrogens. Having more fat tissue can increase a woman's estrogen levels, which increases her endometrial cancer risk. In comparison with women who maintain a healthy weight, endometrial cancer is twice as common in overweight women, and more than three times as common in obese women.
Tamoxifen is a drug that is used to prevent and treat breast cancer. Tamoxifen acts as an anti-estrogen in breast tissue, but it acts like an estrogen in the uterus. In women who have gone through menopause, it can cause the uterine lining to grow, which increases the risk of endometrial cancer.
The risk of developing endometrial cancer from tamoxifen is low (less than 1% per year). Women taking tamoxifen must balance this risk against the value of this drug in treating and preventing breast cancer. This is an issue women should discuss with their doctors. If you are taking tamoxifen, you should have yearly gynecologic exams and should be sure to report any abnormal bleeding, as this could be a sign of endometrial cancer.
A certain type of ovarian tumor, the granulosa-theca cell tumor, often makes estrogen. Estrogen release by one of these tumors is not controlled the way hormone release from the ovaries is, which can sometimes lead to high estrogen levels. The resulting hormone imbalance can stimulate the endometrium and even lead to endometrial cancer. In fact, sometimes vaginal bleeding from endometrial cancer is the first symptom of one of these tumors.
Polycystic ovarian syndrome
Women with a condition called polycystic ovarian syndrome (PCOS) have abnormal hormone levels, such as higher androgen (male hormones) and estrogen levels and lower levels of progesterone. The increase in estrogen relative to progesterone can increase a woman's chance of getting endometrial cancer.
Use of an intrauterine device
Women who used an intrauterine device (IUD) for birth control seem to have a lower risk of getting endometrial cancer. Information about this protective effect is limited to IUDs that do not contain hormones. Researchers have not yet studied whether newer types of IUDs that release progesterone have any effect of endometrial cancer risk. However, these IUDs are sometimes used to treat pre-cancers and early endometrial cancers in women who wish to preserve child-bearing ability.
The risk of endometrial cancer increases as a woman gets older.
Diet and exercise
A high-fat diet can increase the risk of several cancers, including endometrial cancer. Because fatty foods are also high-calorie foods, a high fat diet can lead to obesity, which is a well-known endometrial cancer risk factor. Many scientists think this is the main way in which a high fat diet raises endometrial cancer risk. Some scientists think that fatty foods may also have a direct effect on estrogen metabolism, which increases endometrial cancer risk.
Physical activity protects against endometrial cancer. Several studies found that women who exercised more had a lower risk of this cancer, while in one study women who spent more time sitting had a higher risk. To learn more, you can read the American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention.
Endometrial cancer may be as much as 4 times more common in women with diabetes. Diabetes is more common in people who are overweight, but even people with diabetes who are not overweight have a higher risk of endometrial cancer.
Endometrial cancer tends to run in some families. Some of these families also have an inherited tendency to develop colon cancer. This disorder is called hereditary nonpolyposis colon cancer (HNPCC). Another name for HNPCC is Lynch syndrome. In most cases, this disorder is caused by a defect in either the gene MLH1 or the gene MSH2. But at least 5 other genes can cause HNPCC: MLH3, MSH6, TGBR2, PMS1, and PMS2. An abnormal copy of any one of these genes reduces the body's ability to repair damage to its DNA. This results in a very high risk of colon cancer, as well as a high risk of endometrial cancer. Women with this syndrome have a 40% to 60% risk of developing endometrial cancer sometime during their lives. The risk of ovarian cancer is also increased. General information about inherited cancer syndromes can be found in our document Heredity and Cancer.
There are some families that have a high rate of only endometrial cancer. These families may have a different genetic disorder that hasn't been discovered yet.
Breast or ovarian cancer
Women who have had breast cancer or ovarian cancer may have an increased risk of developing endometrial cancer. Some of the dietary, hormonal, and reproductive risk factors for breast and ovarian cancer also increase endometrial cancer risk.
Prior pelvic radiation therapy
Radiation used to treat some other cancers can damage the DNA of cells, sometimes increasing the risk of a second type of cancer such as endometrial cancer.
Endometrial hyperplasia is an increased growth of the endometrium. Mild or simple hyperplasia, the most common type, has a very small risk of becoming cancerous. It may go away on its own or after treatment with hormone therapy. If the hyperplasia is called “atypical,” it has a higher chance of becoming a cancer. Simple atypical hyperplasia turns into cancer in about 8% of cases if it is not treated. Complex atypical hyperplasia (CAH) has a risk of becoming cancerous if not treated in up to 29% of cases. For this reason, CAH is usually treated. (Treatment is discussed in the section "Can endometrial cancer be prevented?")
Last Medical Review: 11/04/2013
Last Revised: 02/03/2014